Augmedix, Inc. Common Stock
AUGX
AUGX was delisted on the 1st of October, 2024.
28 hedge funds and large institutions have $33.8M invested in Augmedix, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 5 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
160% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 5
12% more funds holding
Funds holding: 25 → 28 (+3)
19% less capital invested
Capital invested by funds: $41.6M → $33.8M (-$7.79M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Samjo Capital
New York
|
+$360K |
| 2 |
TC
TownSquare Capital
Provo,
Utah
|
+$170K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$165K |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$154K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$39.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIV
DCM International VI
Menlo Park,
California
|
-$462K |
| 2 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$145K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.68K |
| 4 |
BlackRock
New York
|
-$1.65K |
| 5 |
KXA
KPCB XV Associates
Menlo Park,
California
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $1K | – | – | – |
|
27
Wells Fargo
San Francisco,
California
| $1K | +$87 | +51 | +5% |
|
|
KXA
28
KPCB XV Associates
Menlo Park,
California
| – | -$1K | -708 | Closed |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$329 | +192 | New |
|
AUGX Hedge Fund Activity: Q3 2022 in Review
28 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q3 2022, worth a combined $33.8M — down 19% from $41.6M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new AUGX positions and 1 closed out — a net gain of 3 holders — while 13 added to existing stakes and 5 trimmed.
The largest buyer was Samjo Capital, adding an estimated $360K. The largest seller was DCM International VI, cutting an estimated $462K.
- 28 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q3 2022, up from 25 in Q2 2022.
- Funds reported $33.8M of Augmedix, Inc. Common Stock stock for Q3 2022, down 19% quarter-over-quarter.
- 4 funds opened new Augmedix, Inc. Common Stock positions in Q3 2022 and 1 closed out, a net change of +3 holders.
- The largest Augmedix, Inc. Common Stock buyer in Q3 2022 was Samjo Capital, an estimated $360K added.
- The largest Augmedix, Inc. Common Stock seller in Q3 2022 was DCM International VI, an estimated $462K sold.
Based on aggregated 13F filings for Q3 2022.